Recruiting

Who we are

  • December 8, 2022
    Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
  • September 19, 2022
    An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
  • July 26, 2022
    GCC19CART for Patients With Metastatic Colorectal Cancer
  • April 5, 2022
    A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
  • April 5, 2022
    Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
  • April 5, 2022
    Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
  • April 5, 2022
    PIPAC for the Treatment of Colorectal Peritoneal Metastases
  • April 5, 2022
    Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
  • April 5, 2022
    The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
  • April 5, 2022
    A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)